… Addition of tiotropium (delivered via the dry-powder HandiHaler device [Boehringer Ingelheim,
Ingelheim am Rhein, Germany]) to beclomethasone (two puffs of 40 μg twice daily) was …

… This 12-week randomised, parallel-group study compared the efficacy of indacaterol 150
μg once-daily to salmeterol 50 μg twice-daily in patients with moderate-to-severe COPD. …

… salmeterol treatment compared to salbutamol treatment subgroups. The results of the study
clearly demonstrate that salmeterol, … -blind, double dummy, parallel-group design throughout …

… study compares a dual bronchodilator (QVA149; a once-daily, … LABA and ICS (salmeterol–fluticasone
[SFC]; twice a day), in … Our study hopes to address the question of whether, in a …

… during treatment with ICS plus salmeterol versus ICS alone (66 studies [N = 20,966], of which
6 were in pediatrics [n = 1575]) concluded that salmeterol combined with ICS significantly …

… This study shows that salmeterol at both dose levels, 50 ltg and 100/tg twice daily, is an
effective … The study was double-blind parallel-grouped and randomized in design, comparing …

… , double-blind, double-dummy, parallel group study to compare the effects of 16 weeks of
treatment with either salmeterol (… The aim was to quantify the within-group treatment effects as …

… The purpose of the present study was therefore to evaluate the … salbutamol after regular
exposure to twice daily salmeterol. … Compared with placebo, salmeterol produced a parallel right …

… This was a multicentre, blinded, placebo-controlled parallel group 12-week study. After a
pre-… take SAL/FP twice daily and had salbutamol to use as rescue medication during the study. …

… , double-blind, double-dummy, parallel-group clinical trial with a … This study confirms
that salmeterol, 50 fig twice daily, is … with the control group, twice as many salmeterol-treated …